SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-048040
Filing Date
2024-05-30
Accepted
2024-05-30 17:04:16
Documents
18
Period of Report
2024-03-14
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0207019-8ka1_biomx.htm   iXBRL 8-K/A 36362
2 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS ea020701901ex23-1_biomx.htm EX-23.1 7858
3 AUDITED CONSOLIDATED FINANCIAL STATEMENTS OF ADAPTIVE PHAGE THERAPEUTICS, INC. A ea020701901ex99-1_biomx.htm EX-99.1 341946
4 UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENTS OF OPERATIONS OF BIOMX INC. AS ea020701901ex99-2_biomx.htm EX-99.2 101650
9 GRAPHIC ex99-1_001.jpg GRAPHIC 8367
  Complete submission text file 0001213900-24-048040.txt   793255

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE phge-20240314.xsd EX-101.SCH 3919
6 XBRL DEFINITION FILE phge-20240314_def.xml EX-101.DEF 26852
7 XBRL LABEL FILE phge-20240314_lab.xml EX-101.LAB 37192
8 XBRL PRESENTATION FILE phge-20240314_pre.xml EX-101.PRE 25476
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0207019-8ka1_biomx_htm.xml XML 7281
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38762 | Film No.: 241006400
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)